These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32894102)

  • 1. HIV-1 infection among women in Israel, 2010-2018.
    Wagner T; Olshtain-Pops K; Wax M; Horwitz O; Shirazi R; Gozlan Y; Volnowitz H; Mendelson E; Levy I; Mor O
    BMC Infect Dis; 2020 Sep; 20(1):660. PubMed ID: 32894102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018.
    Wagner T; Zuckerman NS; Halperin T; Chemtob D; Levy I; Elbirt D; Shachar E; Olshtain-Pops K; Elinav H; Chowers M; Itsomin V; Riesenberg K; Wax M; Shirazi R; Gozlan Y; Matus N; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.
    Moscona R; Ram D; Wax M; Bucris E; Levy I; Mendelson E; Mor O
    J Int AIDS Soc; 2017 Aug; 20(1):21846. PubMed ID: 28799325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Diversity and Drug Resistance in Treatment-Naïve Children and Adolescents from Rio de Janeiro, Brazil.
    de Azevedo SSD; Delatorre E; Gaido CM; Silva-de-Jesus C; Guimarães ML; Couto-Fernandez JC; Morgado MG
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients.
    Clevenbergh P; Cua E; Dam E; Durant J; Schmit JC; Boulme R; Cottalorda J; Beyou A; Schapiro JM; Clavel F; Dellamonica P
    HIV Clin Trials; 2002; 3(1):36-44. PubMed ID: 11819184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual intermingling of Arab and Jewish MSM in Israel: results of a molecular epidemiology study.
    Zuckerman NS; Mor Z; Bucris E; Wax M; Mendelson E; Mor O
    AIDS; 2019 Feb; 33(2):339-344. PubMed ID: 30325775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.
    SPREAD programme
    AIDS; 2008 Mar; 22(5):625-35. PubMed ID: 18317004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.
    Sadeghi L; Lolaie M; Tabatabai RA; Bayanolhagh S; Taj L; Ahmadi NE; Abedinzadeh N; Vakili F; Ahmadi G; Mohraz M
    Infect Disord Drug Targets; 2018; 18(3):241-248. PubMed ID: 29663899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.
    Yebra G; de Mulder M; Pérez-Elías MJ; Pérez-Molina JA; Galán JC; Llenas-García J; Moreno S; Holguín Á
    PLoS One; 2011; 6(10):e26757. PubMed ID: 22046345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevalence of primary HIV-1 drug resistance in newly reported HIV infections in Henan].
    Liu J; Xu W; He C; Yan J; Xing H; Xue XJ; Sun DY; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):643-7. PubMed ID: 27188354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of transmitted HIV drug resistance in Europe vary by risk group.
    Frentz D; van de Vijver D; Abecasis A; Albert J; Hamouda O; Jørgensen L; Kücherer C; Struck D; Schmit JC; Vercauteren J; Asjö B; Balotta C; Bergin C; Beshkov D; Camacho R; Clotet B; Griskevicius A; Grossman Z; Horban A; Kolupajeva T; Korn K; Kostrikis L; Linka KL; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Stanekova D; Stanojevic M; Vandamme AM; Boucher C; Wensing A;
    PLoS One; 2014; 9(4):e94495. PubMed ID: 24721998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug resistance mutations and its associated factors among 579 HIV/AIDS patients experiencing failure of antiretroviral therapy in Jiangsu Province, China].
    Xiao PP; Lu J; Hu HY; Xu XQ; Ding P; Fu GF; Huan XP; Zhou Y; Yang HT
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):988-993. PubMed ID: 29136743
    [No Abstract]   [Full Text] [Related]  

  • 14. Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil.
    Pilotto JH; Grinsztejn B; Veloso VG; Velasque LS; Friedman RK; Moreira RI; Rodrigues-Pedro A; Oliveira SM; Currier JS; Morgado MG
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):681-6. PubMed ID: 23259924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.
    Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A
    Antivir Ther; 2014; 19(8):813-8. PubMed ID: 24699043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
    Whitcomb JM; Huang W; Limoli K; Paxinos E; Wrin T; Skowron G; Deeks SG; Bates M; Hellmann NS; Petropoulos CJ
    AIDS; 2002 Oct; 16(15):F41-7. PubMed ID: 12370521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naïve chronically infected Brazilian blood donors.
    Pessôa R; Sanabani SS
    PLoS One; 2017; 12(9):e0185559. PubMed ID: 28953964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
    Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
    South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.